Treating-to-target or treating the patient in rheumatoid arthritis? by Taylor, PC, Pope, J

Making it personal: Developing sustainability leaders in business by Haney, AB, Pope, J, Arden, Z

Turing, ciphers and quanta. by Ekert, A, Kay, A, Pope, J

The key comorbidities in patients with rheumatoid arthritis: a narrative review by Taylor, PC, Atzeni, F, Balsa, A, Gossec, L, Müller-Ladner, U, Pope, J

Effects of reduced measurement independence on bell-based randomness expansion by Koh, D, Hall, M, Setiawan, Pope, J, Marletto, C, Kay, A, Scarani, V, Ekert, A

Effects of reduced measurement independence on Bell-based randomness expansion. by Koh, D, Hall, M, Setiawan, Pope, J, Marletto, C, Kay, A, Scarani, V, Ekert, A

Effect of filgotinib on pain in patients with rheumatoid arthritis: results from phase 3 clinical trials by Pope, J, Taylor, P, Kavanaugh, A, Nash, P, Bartok, B, Hasegawa, K, Rao, S, Strengholt, S, Westhovens, R

Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention by Pope J, Finckh A, Silva-Fernández L, Mandl P, Fan H, Rivas JL, Valderrama M, Montoro M

Get full text

Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis by Taylor, P, Takeuchi, T, Burmester, G, Durez, P, Smolen, J, Deberdt, W, Zhong, J, Teres, JR, Bello, N, Winthrop, K, Pope, J

Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM by Fautrel, B, Kirkham, B, Pope, J, Takeuchi, T, Gaich, C, Quebe, A, Zhu, B, De La Torre, I, De Leonardis, F, Taylor, P

Patient disease trajectories in rheumatoid arthritis patients treated with baricitinib 4-mg in 4 phase 3 clinical studies by Taylor, PC, Chen, YF, Pope, J, Weinblatt, M, Mysler, E, Rubbert-Roth, A, Jia, B, Sun, L, Liu, Y, Holzkämper, T, Tanaka, Y

Systematic literature review of residual symptoms and an unmet need in patients with rheumatoid arthritis by Michaud, K, Pope, J, van de Laar, M, Curtis, JR, Kannowski, C, Mitchell, S, Bell, J, Workman, J, Paik, J, Cardoso, A, Taylor, PC

Baricitinib 4mg and 2mg once-daily reduced pain in both patients who were opioid users and non-users in active rheumatoid arthritis: a post-hoc analysis of phase 3 trials by Pope, J, Lee, Y, Curtis, J, Mo, D, Rooney, T, Xie, L, Dickson, C, Schlichting, D, Quebe, A, Cardoso, A, Simon, L, Taylor, P

Impact of filgotinib on pain control in the phase 3 FINCH studies by Taylor, PC, Kavanaugh, A, Nash, P, Pope, J, Pongratz, G, Fautrel, B, Alten, R, Hasegawa, K, Rao, S, de Vries, D, Stiers, P-J, Watson, C, Westhovens, R

Benefits of pain relief on fatigue, function, and quality of life when joint inflammation is controlled in patients with RA by Van De Laar, M, Pope, J, Lee, Y, Fautrel, B, Ikeda, K, Quebe, A, Zhang, X, Gaich, C, De Leonardis, F, Lisse, J, Workman, J, Taylor, P

Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors by Taylor, P, Fleischmann, R, Takeuchi, T, Pope, J, Genovese, M, Zhu, B, Gaich, C, Zhang, X, Dickson, C, Quebe, A, De Leonardis, F, Cardoso, A, Kouris, I, Durez, P

Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations by Bancroft, E, Saya, S, Page, E, Myhill, K, Thomas, S, Pope, J, Chamberlain, A, Hart, R, Glover, W, Cook, J, Rosario, D, Helfand, B, Hutten Selkirk, C, Davidson, R, Longmuir, M, Eccles, D, Gadea, N, Brewer, C, Barwell, J, Salinas, M, Greenhalgh, L, Tischkowitz, M, Henderson, A, Evans, D, Buys, S, Impact Study Steering Committee, Impact Collaborators, Hamdy, F, Eeles, R, Aaronson, N

The neuromodulation appropriateness consensus committee on best practices for dorsal root ganglion stimulation by Deer, T, Pope, J, Lamer, T, Grider, J, Provenzano, D, Lubenow, T, Fitzgerald, J, Hunter, C, Falowski, S, Sayed, D, Baranidharan, G, Patel, N, Davis, T, Green, A, Pajuelo, A, Epstein, L, Harned, M, Liem, L, Christo, P, Chakravarthy, K, Gilmore, C, Huygen, F, Lee, E, Metha, P, Nijhuis, H, Patterson, D, Petersen, E, Pilitsis, J, Rowe, J, Rupert, M, Skaribas, I, Sweet, J, Verrills, P, Wilson, D, Levy, R, Mekhail, N

Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers by Page, EC, Bancroft, EK, Brook, MN, Assel, M, Battat, M, Thomas, S, Taylor, N, Chamberlain, A, Pope, J, Raghallaigh, HN, Evans, DG, Rothwell, J, Mahle, L, Grindedal, EMM, James, P, Mascarenhas, L, McKinley, J, Side, L, Thomas, T, Van Asperen, C, Vasen, H, Kiemeney, LA, Ringelberg, J, Jensen, TD, Osther, PJS, Helfand, BT, Genova, E, Oldenburg, RA, Cybulski, C, Wokolorczyk, D, Ong, K-R, Huber, C, Lam, J, Taylor, L, Salinas, M, Feliubadaló, L, Oosterwijk, JC, Van Zelst-Stams, W, Cook, J, Rosario, DJ, Domchek, S, Powers, J, Buys, S, O'Toole, K, Ausems, MGEM, Schmutzler, RK, Rhiem, K, Izatt, L, Tripathi, V, Teixeira, MR, Cardoso, M, Foulkes, WD, Aprikian, A, Van Randeraad, H, Davidson, R, Longmuir, M, Ruijs, MWG, Van Den Enden, ATJM, Adank, M, Williams, R, Andrews, L, Murphy, DG, Halliday, D, Walker, L, Liljegren, A, Carlsson, S, Azzabi, A, Jobson, I, Morton, C, Shackleton, K, Snape, K, Hanson, H, Harris, M, Tischkowitz, M, Taylor, A, Kirk, J, Susman, R, Chen-Shtoyerman, R, Spigelman, A, Pachter, N, Ahmed, M, Cajal, T, Zgajnar, J, Brewer, C, Gadea, N, Brady, AF, Van Os, T, Gallagher, D, Johannsson, O, Donaldson, A, Barwell, J, Nicolai, N, Friedman, E, Obeid, E, Greenhalgh, L, Murthy, V, Copakova, L, Saya, S, McGrath, J, Cooke, P, Rønlund, K, Richardson, K, Henderson, A, Teo, SH, Arun, B, Kast, K, Dias, A, Aaronson, NK, Ardern-Jones, A, Bangma, CH, Castro, E, Dearnaley, D, Eccles, DM, Tricker, K, Eyfjord, J, Falconer, A, Foster, C, Gronberg, H, Hamdy, FC, Stefansdottir, V, Khoo, V, Lindeman, GJ, Lubinski, J, Axcrona, K, Mikropoulos, C, Mitra, A, Moynihan, C, Rennert, G, Suri, M, Wilson, P, Dudderidge, T, Impact Study Collaborators, Offman, J, Kote-Jarai, Z, Vickers, A, Lilja, H, Eeles, RA